Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of vigabatrin (M071754) in infantile spasms
jRCT2080222508Phase 4
- Sponsor
- Alfresa
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vigabatrin in West syndrome, sponsored by Alfresa.
02
Drugs
vigabatrin
03
Conditions
West syndrome
Beyond the preview
Go deeper on jRCT2080222508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222508.